CO News and Press, Global Cord Blood Corporation From 03/02/22

In addition to inflationary pressure, growing concerns about the potential aftermath of the Russia-Ukraine war and the Western and EU economic sanctions imposed on Russia have been fueling immense market volatility. So, we think investors seeking to 'bottom-fish' in the beaten-down market cou...

Gold futures spiked to their highest settlement in more than a year, as Russia's assault on Ukraine's largest cities drives demand for safe-haven gold and as the 10-year Treasury yield tumbles 15 bps to ~1.68%. April Comex gold (XAUUSD:CUR) closed +2.3% at $1,943.80/oz, the best settlement fo...

Global Cord Blood Corporation (CO) Q3 2022 Results Earnings Conference Call March 1, 2022, 08:00 AM ET Company Participants Cathy Bai - Vice President of Corporate Finance Albert Chen - Chief Financial Officer Conference Call Participants Jeff Oliver - Lone Star Funds Presentation Operator We...

Global Cord Blood press release (NYSE:CO): Q3 GAAP EPS of RMB1.11. Revenue of RMB317.2M (+9.1% Y/Y). For further details see: Global Cord Blood GAAP EPS of RMB1.11, revenue of RMB317.2M

Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2022 PR Newswire Added 18,985 New Subscribers in 3Q22 Revenues Up 9.1% YoY to RMB317.2 Million ( $49.8 Million ) Gross Profit Up 9.8% YoY t...

ACAD,ACHC,AGM,AMBA,AMRC,OTCPK:AOIFF,APLS,APPF,APTS,ARCT,ARDX,ASXC,ATRA,AVIR,AY,BANX,BIGC,BLFS,BLNK,BRMK,CAPL,CLDX,CO,CSR,CSTL,DAR,DDD,DNMR,DVAX,ENDP,EVA,FATE,FGEN,FRPT,FSK,GAIA,GDRX,GMRE,GOEV,GPOR,GRPN,HHC,HPQ,HRTX,ICAD,KD,LAZR,LCID,MBI,MDXG,MRTX,NKTR,NMFC,NVAX,NVEE,OCUL,OKE,ONTF,OTIC,PDCE,PG...

Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2022 Financial Results Earnings Call Scheduled for 8:00 a.m. ET on March 1, 2022 PR Newswire HONG KONG , Feb. 23, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ...

The shares of medical diagnostics company Quidel Corporation (QDEL) have lost momentum over the past few months. While the company witnessed strong demand for its rapid Covid antigen testing amid surging coronavirus cases, given its poor growth prospects and an ongoing investigation of its re...

Volume in Global Cord Blood Corp. (NYSE:CO) is up nearly 60 times the normal average after the company posted an SEC Form SC 13 G/A this morning. As of 255p ET, ~3.8M shares had traded hands. Normal volume is 63,219 shares. Most of the ownership in filings were related to Kent C. McCarthy or ...

The shares of medical technology stock Senseonics Holdings (SENS) dipped marginally in price yesterday, despite the company receiving FDA approval for its Eversense E3 glucose monitoring system. So, with unsustainable valuations and a bleak earnings outlook, will SENS'stock be able to regain ...